Charles River Laboratories Intl. Inc vs SPDR Gold Trust — how do they compare? Charles River Laboratories Intl. Inc trades at $303.01 (market cap $14.23B), while SPDR Gold Trust trades at $384.11 (market cap $139.66B). The key difference: SPDR Gold Trust is far larger — about 9.8× Charles River Laboratories Intl. Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and SPDR Gold Trust for 74 Days on average.
| CRL | GLD | |
|---|---|---|
Market Cap | $14.23B | $139.66B |
Volume | 1,176,885 | 9,544,773 |
Sector | Health | — |
52-Week High | $310.77 | $495.90 |
52-Week Low | $149.93 | $362.32 |
Typical Hold Time | 33 Days | 74 Days |
Enterprise Value | $17.06B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GLD, the SPDR Gold Trust ETF, is trading at $384.45 with a 2.28% daily gain, though technical indicators signal bearish momentum with 17 sell signals versus 2 buy signals. The ETF faces pressure from rising Treasury yields and a strong U.S. dollar, as highlighted in recent financial news. Key support levels are at $373-$377, while resistance sits at $380-$384. Recent market sentiment remains cautious amid Federal Reserve policy uncertainty and inflation concerns.
The outlook for GLD is mixed, with near-term headwinds from monetary policy and currency strength potentially limiting upside. However, gold's role as a hedge against inflation and global debt concerns offers long-term diversification benefits. Risks include further rate hikes and dollar appreciation, but tactical buying opportunities may emerge if support levels hold.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →